- Home
- AMPX vs NVCT Comparison
AMPX vs NVCT Comparison
Compare AMPX & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPX
- NVCT
- Stock Information
- Founded
- AMPX 2008
- NVCT 2020
- Country
- AMPX United States
- NVCT United States
- Employees
- AMPX N/A
- NVCT N/A
- Industry
- AMPX Industrial Machinery/Components
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- AMPX Miscellaneous
- NVCT Health Care
- Exchange
- AMPX Nasdaq
- NVCT Nasdaq
- Market Cap
- AMPX 126.6M
- NVCT 117.3M
- IPO Year
- AMPX N/A
- NVCT 2022
- Fundamental
- Price
- AMPX $1.22
- NVCT $6.10
- Analyst Decision
- AMPX Strong Buy
- NVCT Strong Buy
- Analyst Count
- AMPX 7
- NVCT 1
- Target Price
- AMPX $8.17
- NVCT $21.00
- AVG Volume (30 Days)
- AMPX 1.3M
- NVCT 91.9K
- Earning Date
- AMPX 11-07-2024
- NVCT 11-06-2024
- Dividend Yield
- AMPX N/A
- NVCT N/A
- EPS Growth
- AMPX N/A
- NVCT N/A
- EPS
- AMPX N/A
- NVCT N/A
- Revenue
- AMPX $12,423,000.00
- NVCT N/A
- Revenue This Year
- AMPX $66.77
- NVCT N/A
- Revenue Next Year
- AMPX $311.17
- NVCT N/A
- P/E Ratio
- AMPX N/A
- NVCT N/A
- Revenue Growth
- AMPX 216.99
- NVCT N/A
- 52 Week Low
- AMPX $0.61
- NVCT $5.85
- 52 Week High
- AMPX $6.02
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- AMPX 61.12
- NVCT 41.10
- Support Level
- AMPX $0.97
- NVCT $6.06
- Resistance Level
- AMPX $1.13
- NVCT $6.78
- Average True Range (ATR)
- AMPX 0.14
- NVCT 0.38
- MACD
- AMPX 0.03
- NVCT -0.02
- Stochastic Oscillator
- AMPX 75.93
- NVCT 18.35
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high energy density lithium-ion batteries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. All of its revenues is geographically earned in the United States.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.